https://www.selleckchem.com/products/sm-102.html
The modeling also showed that for patients diagnosed with CML after 1995 (compared to before), there was a greater decrease in the probability of dying of the disease in the 4th and 5th years after diagnosis compared to the initial years since diagnosis. The greatest increases in trends for distant melanoma, NHL and CML coincided with the introduction of novel treatments, demonstrating the value of JPSurv for estimating and interpreting cancer survival trends. The JPSurv webtool provides a suite of estimates for analyzing trends in cance